Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 5, Number 3—June 1999
Letter

Hepatitis C Virus RNA Viremia in Central Africa

On This Page
Article Metrics
6
citations of this article
EID Journal Metrics on Scopus

Cite This Article

To the Editor: Epidemiologic serosurveys have demonstrated high prevalence (6%-15%) of hepatitis C virus (HCV) infection in adults in sub-Saharan Africa (1-4). Although possible false-positive HCV serologic test results have been reported in Africa, HCV prevalence rates suggest a high rate of chronic infection among persons with anti-HCV antibodies (5,6). We have focused on HCV RNA infectivity of blood from donors attending the National Blood Center in Bangui, Central African Republic.

We prospectively tested all blood donors between February and April 1998 for serum anti-HCV antibodies by both an HCV third-generation enzyme-linked immunosorbent assay (ELISA) (Abbott HCV EIA 3.0 test, Abbott, Chicago, IL, USA), which was chosen as a reference test for immunoglobulin (Ig) G antibodies to HCV, and by a simple membrane immunoassay system (Ortho HCV Ab Quik Pack, Ortho Diagnostic Systems Inc., Tokyo, Japan) (7). Anti-HCV-positive serum samples were further subjected to qualitative detection of HCV RNA by reverse transcription-polymerase chain reaction (AMPLICOR-HCV, Roche Diagnostic Systems, Inc., Branchburg, NJ, USA) (8). Of 163 serum samples (mean age ± standard deviation, 30±8 years), 155 were from male blood donors, 83 (51%) from first-time donors, and 125 (77%) from donors in the recipient's family. Fifteen (9.2%; 95% confidence interval [CI] 5%-15%) samples contained IgG to HCV by ELISA. Of the ELISA-positive samples, 14 were positive by the Quik Pack assay (sensitivity, 93.0%); of the 148 remaining ELISA-negative samples, 147 were negative by the Quik Pack assay (specificity, 99.3%). The agreement between the results of the two methods was 98.7%. Of the 163 samples, 10 (6.1%; CI 95%: 3%-11%) were positive for HCV antibodies (by ELISA and rapid test) and for HCV RNA.

We confirmed a high prevalence of HCV-seropositivity among blood donors in Bangui and the subsequent high rate of HCV RNA viremic blood donations. To offset the major risk for transfusion-acquired HCV in Central Africa we recommend screening donated blood for anti-HCV. When laboratory facilities to perform ELISA are not available, the Quik Pack system, a simple reliable method for detecting anti-HCV antibodies in human serum that requires neither complex reagent preparation nor expensive instrumentation, could prove useful.

Top

Nicole Cancré*, Gérard Grésenguet†, François-Xavier Mbopi-Kéou‡, Alain Kozemaka†, Ali Si Mohamed*, Mathieu Matta*, Jean-Jacques Fournel§, and Laurent Bélec*
Author affiliations: *Université Pierre et Marie Curie, Hôpital Broussais, Paris, France; †Centre National de Transfusion Sanguine, Bangui, République Centrafricaine; ‡London School of Hygiene and Tropical Medicine, London, United-Kingdom; and; §Hôpital de la Pitié-Salpêtrière, Paris, France

Top

References

  1. Ndumbe  PM, Skalsky  J. Hepatitis C virus infection in different populations in Cameroon. Scand J Infect Dis. 1993;25:68992. DOIPubMedGoogle Scholar
  2. Xu  LZ, Larzul  D, Delaporte  E, Bréchot  C, Kremsdorf  D. Hepatitis C virus genotype 4 highly prevalent in Central Africa (Gabon). J Gen Virol. 1994;75:23938. DOIPubMedGoogle Scholar
  3. Fretz  C, Jeannel  D, Stuyver  L, Herve  V, Lunel  F, Boudifa  A, HCV Infection in a rural population of Central African Republic (CAR): evidence for three additional subtypes of genotype 4. J Med Virol. 1995;47:4357. DOIPubMedGoogle Scholar
  4. Pawlotsky  JM, Bélec  L, Grésenguet  G, Desforges  L, Bouvier  M, Duval  J, High prevalence of hepatitis B, C and E markers in young sexually active adults from the Central African Republic. J Med Virol. 1995;46:26973. DOIPubMedGoogle Scholar
  5. Aceti  A, Taliani  D. Hepatitis C virus testing in African sera. Ann Intern Med. 1992;116:427.PubMedGoogle Scholar
  6. Callahan  JD, Constantine  NT, Kataaha  P, Zhang  X, Hyams  KC, Bansal  J. Second generation hepatitis C virus assays: performance when testing African sera. J Med Virol. 1993;41:358. DOIPubMedGoogle Scholar
  7. Kodama  T, Ichiyama  S, Sato  K, Nada  T, Nakashima  N. Evaluation of a membrane filter assay system, Ortho HCV Ab Quik Pack, for detection of anti-hepatitis C virus antibody. J Clin Microbiol. 1998;36:143940.PubMedGoogle Scholar
  8. Young  KKY. R. Resnick RM, Myers TW. Detection of hepatitis C virus RNA by a combined reverse transcription-polymerase chain reaction assay. J Clin Microbiol. 1993;31:8826.PubMedGoogle Scholar

Top

Cite This Article

DOI: 10.3201/eid0503.990330

Related Links

Top

Table of Contents – Volume 5, Number 3—June 1999

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.

Top

Page created: December 13, 2010
Page updated: December 13, 2010
Page reviewed: December 13, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external